For example, Zhang et al. found that inhibition of miR-21, a miRNA enriched in fibrotic tissues, dramatically reduced HSC activation and ameliorated liver fibrosis by inhibiting the transforming growth factor- β (TGF-β) pathway (Zhang et al., 2013). This evidence concerns the gene TGFB1 and Hepatic fibrosis.